Teigler-Schlegel A - Search Results

1

Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.

Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D. Langebrake C, et al. Cytometry B Clin Cytom. 2005 Jan;63(1):1-9. doi: 10.1002/cyto.b.20037. Cytometry B Clin Cytom. 2005. PMID: 15624201 Free article.

2

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16).

Creutzig U, Zimmermann M, Bourquin JP, Dworzak MN, von Neuhoff C, Sander A, Schrauder A, Teigler-Schlegel A, Stary J, Corbacioglu S, Reinhardt D. Creutzig U, et al. Blood. 2011 Nov 17;118(20):5409-15. doi: 10.1182/blood-2011-07-364661. Epub 2011 Sep 26. Blood. 2011. PMID: 21948298 Free article.

3

Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.

Viehmann S, Teigler-Schlegel A, Bruch J, Langebrake C, Reinhardt D, Harbott J. Viehmann S, et al. Leukemia. 2003 Jun;17(6):1130-6. doi: 10.1038/sj.leu.2402959. Leukemia. 2003. PMID: 12764380

4

AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid.

Classen CF, Teigler-Schlegel A, Röttgers S, Reinhardt D, Döhner K, Debatin KM. Classen CF, et al. Ann Hematol. 2005 Nov;84(12):774-80. doi: 10.1007/s00277-005-1089-2. Epub 2005 Nov 12. Ann Hematol. 2005. PMID: 16044313

5

Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.

Attarbaschi A, Panzer-Grümayer R, Mann G, Möricke A, König M, Mecklenbräuker A, Teigler-Schlegel A, Bradtke J, Harbott J, Göhring G, Stanulla M, Schrappe M, Zimmermann M, Haas OA; Austrian and German ALL-BFM (Berlin-Frankfurt-Münster) Study Group. Attarbaschi A, et al. Among authors: teigler schlegel a. Klin Padiatr. 2014 Nov;226(6-7):338-43. doi: 10.1055/s-0034-1387795. Epub 2014 Nov 28. Klin Padiatr. 2014. PMID: 25431866 Clinical Trial.

6

Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.

Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M, Zimmermann M, Ludwig WD, Janka-Schaub G, Schrappe M, Harbott J. Borkhardt A, et al. Leukemia. 2002 Sep;16(9):1685-90. doi: 10.1038/sj.leu.2402595. Leukemia. 2002. PMID: 12200682 Clinical Trial.

7

MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways.

Daschkey S, Röttgers S, Giri A, Bradtke J, Teigler-Schlegel A, Meister G, Borkhardt A, Landgraf P. Daschkey S, et al. PLoS One. 2013;8(2):e56334. doi: 10.1371/journal.pone.0056334. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418555 Free PMC article.

8

Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.

Yoshimi A, Strahm B, Baumann I, Furlan I, Schwarz S, Teigler-Schlegel A, Walther JU, Schlegelberger B, Göhring G, Nöllke P, Führer M, Niemeyer CM. Yoshimi A, et al. Among authors: teigler schlegel a. Biol Blood Marrow Transplant. 2014 Mar;20(3):425-9. doi: 10.1016/j.bbmt.2013.11.031. Epub 2013 Dec 5. Biol Blood Marrow Transplant. 2014. PMID: 24316460 Free article. Clinical Trial.

9

Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR).

Weber A, Taube S, Zur Stadt U, Horstmann M, Krohn K, Bradtke J, Teigler-Schlegel A, Leiblein S, Christiansen H. Weber A, et al. Exp Hematol Oncol. 2012 Nov 9;1(1):33. doi: 10.1186/2162-3619-1-33. Exp Hematol Oncol. 2012. PMID: 23210797 Free PMC article.

10

An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML-M2.

Borkhardt A, Teigler-Schlegel A, Fuchs U, Keller C, König M, Harbott J, Haas OA. Borkhardt A, et al. Genes Chromosomes Cancer. 2001 Sep;32(1):82-8. doi: 10.1002/gcc.1169. Genes Chromosomes Cancer. 2001. PMID: 11477664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters